These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17488727)

  • 41. Cerebellar soluble mutant ataxin-3 level decreases during disease progression in Spinocerebellar Ataxia Type 3 mice.
    Nguyen HP; Hübener J; Weber JJ; Grueninger S; Riess O; Weiss A
    PLoS One; 2013; 8(4):e62043. PubMed ID: 23626768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocation.
    Hübener J; Vauti F; Funke C; Wolburg H; Ye Y; Schmidt T; Wolburg-Buchholz K; Schmitt I; Gardyan A; Driessen S; Arnold HH; Nguyen HP; Riess O
    Brain; 2011 Jul; 134(Pt 7):1925-42. PubMed ID: 21653538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3.
    Boy J; Schmidt T; Wolburg H; Mack A; Nuber S; Böttcher M; Schmitt I; Holzmann C; Zimmermann F; Servadio A; Riess O
    Hum Mol Genet; 2009 Nov; 18(22):4282-95. PubMed ID: 19666958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potassium channel dysfunction and depolarized resting membrane potential in a cell model of SCA3.
    Jeub M; Herbst M; Spauschus A; Fleischer H; Klockgether T; Wuellner U; Evert BO
    Exp Neurol; 2006 Sep; 201(1):182-92. PubMed ID: 16765348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3.
    Toonen LJ; Schmidt I; Luijsterburg MS; van Attikum H; van Roon-Mom WM
    Sci Rep; 2016 Oct; 6():35200. PubMed ID: 27731380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript.
    Ramani B; Harris GM; Huang R; Seki T; Murphy GG; Costa Mdo C; Fischer S; Saunders TL; Xia G; McEachin RC; Paulson HL
    Hum Mol Genet; 2015 Mar; 24(5):1211-24. PubMed ID: 25320121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix.
    Perez MK; Paulson HL; Pittman RN
    Hum Mol Genet; 1999 Dec; 8(13):2377-85. PubMed ID: 10556285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation.
    Chou AH; Chen YL; Hu SH; Chang YM; Wang HL
    Brain Res; 2014 Oct; 1583():220-9. PubMed ID: 25139423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional interactions as a survival strategy against abnormal aggregation.
    Masino L; Nicastro G; Calder L; Vendruscolo M; Pastore A
    FASEB J; 2011 Jan; 25(1):45-54. PubMed ID: 20810784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polyglutamine-Independent Features in Ataxin-3 Aggregation and Pathogenesis of Machado-Joseph Disease.
    Carvalho AL; Silva A; Macedo-Ribeiro S
    Adv Exp Med Biol; 2018; 1049():275-288. PubMed ID: 29427109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation.
    Chou AH; Yeh TH; Ouyang P; Chen YL; Chen SY; Wang HL
    Neurobiol Dis; 2008 Jul; 31(1):89-101. PubMed ID: 18502140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calpain-1 ablation partially rescues disease-associated hallmarks in models of Machado-Joseph disease.
    Weber JJ; Haas E; Maringer Y; Hauser S; Casadei NLP; Chishti AH; Riess O; Hübener-Schmid J
    Hum Mol Genet; 2020 Apr; 29(6):892-906. PubMed ID: 31960910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
    Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
    J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3.
    Evert BO; Vogt IR; Vieira-Saecker AM; Ozimek L; de Vos RA; Brunt ER; Klockgether T; Wüllner U
    J Neuropathol Exp Neurol; 2003 Oct; 62(10):1006-18. PubMed ID: 14575237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo.
    Ikeda H; Yamaguchi M; Sugai S; Aze Y; Narumiya S; Kakizuka A
    Nat Genet; 1996 Jun; 13(2):196-202. PubMed ID: 8640226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PolyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner.
    Jia NL; Fei EK; Ying Z; Wang HF; Wang GH
    Neurosci Bull; 2008 Aug; 24(4):201-8. PubMed ID: 18668148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homozygosity enhances severity in spinocerebellar ataxia type 3.
    Carvalho DR; La Rocque-Ferreira A; Rizzo IM; Imamura EU; Speck-Martins CE
    Pediatr Neurol; 2008 Apr; 38(4):296-9. PubMed ID: 18358414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Subcellular localization of ataxin-3 and its effect on the morphology of cytoplasmic organoids].
    Wei F; Xiao H; Hu Z; Zhang H; Wang C; Dai H; Tang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Jun; 32(3):353-7. PubMed ID: 26037349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease.
    Nascimento-Ferreira I; Santos-Ferreira T; Sousa-Ferreira L; Auregan G; Onofre I; Alves S; Dufour N; Colomer Gould VF; Koeppen A; Déglon N; Pereira de Almeida L
    Brain; 2011 May; 134(Pt 5):1400-15. PubMed ID: 21478185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CDK5 protects from caspase-induced Ataxin-3 cleavage and neurodegeneration.
    Liman J; Deeg S; Voigt A; Voßfeldt H; Dohm CP; Karch A; Weishaupt J; Schulz JB; Bähr M; Kermer P
    J Neurochem; 2014 Jun; 129(6):1013-23. PubMed ID: 24548080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.